Explore more publications!
Palestine Health Report
Got News to Share?

Palestine Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Palestine Health Report.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on January 23, 2026

Countdown for a Cure Partners with Dr. Taz Bhatia M.D. and hol+ to Advance Mitochondrial Research and Awareness
Jan. 23, 2026

Countdown for a Cure Partners with Dr. Taz Bhatia M.D. and hol+ to Advance Mitochondrial Research and Awareness

Indeterminate GlobeNewswire
Environmental Mass Spectrometry Market to Reach USD 1.47 Billion by 2031 | MarketsandMarkets™
Jan. 23, 2026

Environmental Mass Spectrometry Market to Reach USD 1.47 Billion by 2031 | MarketsandMarkets™

Indeterminate GlobeNewswire
20 Million Patients Benefit from da Vinci Surgery Globally
Jan. 23, 2026

20 Million Patients Benefit from da Vinci Surgery Globally

Indeterminate GlobeNewswire
Global Polymeric Biomaterials Market to Reach USD 16.93 Billion by 2030 | MarketsandMarkets™
Jan. 23, 2026

Global Polymeric Biomaterials Market to Reach USD 16.93 Billion by 2030 | MarketsandMarkets™

Indeterminate GlobeNewswire
BioCryst Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema 
Jan. 23, 2026

BioCryst Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema 

Indeterminate GlobeNewswire
Global Protein Expression Market Poised for 10.9% CAGR Expansion by 2030
Jan. 23, 2026

Global Protein Expression Market Poised for 10.9% CAGR Expansion by 2030

Indeterminate GlobeNewswire
Enovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th
Jan. 23, 2026

Enovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th

Indeterminate GlobeNewswire
Lexicon Pharmaceuticals to Ring the Nasdaq Closing Bell on January 27, 2026 to Celebrate 30th Anniversary
Jan. 23, 2026

Lexicon Pharmaceuticals to Ring the Nasdaq Closing Bell on January 27, 2026 to Celebrate 30th Anniversary

Indeterminate GlobeNewswire
Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress
Jan. 23, 2026

Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress

Indeterminate GlobeNewswire
Adagene Provides Business Update and 2026 Objectives
Jan. 23, 2026

Adagene Provides Business Update and 2026 Objectives

Indeterminate GlobeNewswire
Daxor Corporation Announces $9 Million Registered Direct Offering
Jan. 23, 2026

Daxor Corporation Announces $9 Million Registered Direct Offering

Indeterminate GlobeNewswire
Aeroflow Health CEO Casey Hite Named to The Healthcare Technology Report’s Top Healthcare Technology CEOs of 2025 List
Jan. 23, 2026

Aeroflow Health CEO Casey Hite Named to The Healthcare Technology Report’s Top Healthcare Technology CEOs of 2025 List

Indeterminate GlobeNewswire
Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq
Jan. 23, 2026

Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq

Indeterminate GlobeNewswire
Ocugen, Inc. Announces Closing of $22.5 Million Underwritten Registered Direct Offering of Common Stock
Jan. 23, 2026

Ocugen, Inc. Announces Closing of $22.5 Million Underwritten Registered Direct Offering of Common Stock

Indeterminate GlobeNewswire
Alveus Therapeutics Announces FDA Clearance of IND and First Patient Dosed in Phase 1b Trial of ALV-100 for Obesity
Jan. 23, 2026

Alveus Therapeutics Announces FDA Clearance of IND and First Patient Dosed in Phase 1b Trial of ALV-100 for Obesity

Indeterminate GlobeNewswire
AMN Healthcare to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Thursday, February 19, 2026
Jan. 23, 2026

AMN Healthcare to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Thursday, February 19, 2026

Indeterminate GlobeNewswire
Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance
Jan. 23, 2026

Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance

Indeterminate GlobeNewswire
NextCure Provides Business Update 
Jan. 23, 2026

NextCure Provides Business Update 

Indeterminate GlobeNewswire
Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at the American Society of Transplant Surgeons Winter Symposium
Jan. 23, 2026

Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at the American Society of Transplant Surgeons Winter Symposium

Indeterminate GlobeNewswire
FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain
Jan. 23, 2026

FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions